title: [THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES].
abstract: The study was carried out to analyze rate of expression of antigens CD35 and CD21 in norm and under different forms of B-cell lymphoproliferative diseases. The level of average intensity of fluorescence of antigens CD35, CD21 and CD200 is compared for different groups of patients with B-cell lymphoproliferative diseases. The established patterns of expression of antigens CD35 and CD21 under B-cell lymphoproliferative diseases permit considering expression of the given markers as a characteristic of differential diagnostic.
authors.forename: O N
authors.initials: ON
authors.lastname: Chibisova
authors.forename: D V
authors.initials: DV
authors.lastname: Burtsev
authors.forename: K M
authors.initials: KM
authors.lastname: Galstian
authors.forename: G I
authors.initials: GI
authors.lastname: Lugovskaia
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D003937:Diagnosis, Differential; D005260:Female; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000175:diagnosis; D016393:Lymphoma, B-Cell / Q000097:blood / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D017463:Receptors, Complement 3b / Q000097:blood*; D017464:Receptors, Complement 3d / Q000097:blood*
chemical_list: D014408:Biomarkers, Tumor; C509991:CR1 protein, human; D009363:Neoplasm Proteins; D017463:Receptors, Complement 3b; D017464:Receptors, Complement 3d